Valuation: ResMed, Inc.

Market Cap 3.01TCr 2.63TCr 2.43TCr 2.24TCr 4.26TCr 2,87000Cr 4.33TCr 29TCr 11TCr 1,40900Cr 11TCr 11TCr 4,88200Cr P/E 2026 *
19.7x
P/E 2027 * 18.5x
Enterprise Value 2.92TCr 2.56TCr 2.36TCr 2.18TCr 4.14TCr 2,78900Cr 4.21TCr 28TCr 11TCr 1,37000Cr 11TCr 11TCr 4,74400Cr EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.77x
Free-Float
75.61%
Yield 2026 *
1.17%
Yield 2027 * 1.27%
1 day+1.27%
1 week-0.56%
Current month+6.96%
1 month+5.84%
3 months-8.57%
6 months-17.44%
Current year-13.46%
1 week 205
Extreme 205
222.43
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%-0.56%-18.57%-3.41% 3.01TCr
+2.86%+0.24%+24.97%+2.14% 19TCr
-0.86%-3.39%-22.07%+24.23% 15TCr
+0.40%-0.33%-56.30%-13.96% 6.69TCr
-2.47%-3.22%+18.32%+1.19% 5.26TCr
+0.07%-1.77%-28.21%-30.90% 4.38TCr
+3.50%+2.22%+10.13%+14.18% 3.77TCr
+2.44%-0.57%+8.00%+42.77% 3.7TCr
+0.03%-1.32%-14.32%-18.74% 2.94TCr
+3.17%+2.69%+98.85%+5.69% 2.93TCr
Average +1.11%-1.48%+2.08%+2.32% 6.68TCr
Weighted average by Cap. +1.19%-1.64%+0.31%+5.02%

Financials

2026 *2027 *
Net sales 565.03Cr 494.29Cr 455.82Cr 421.74Cr 800.49Cr 54TCr 813.87Cr 5.46TCr 2.14TCr 26TCr 2.12TCr 2.08TCr 92TCr 597.43Cr 522.64Cr 481.96Cr 445.93Cr 846.4Cr 57TCr 860.54Cr 5.77TCr 2.26TCr 28TCr 2.24TCr 2.19TCr 97TCr
Net income 154.9Cr 135.51Cr 124.96Cr 115.62Cr 219.45Cr 15TCr 223.12Cr 1.5TCr 586.62Cr 7.26TCr 581.51Cr 568.93Cr 25TCr 164.99Cr 144.33Cr 133.1Cr 123.15Cr 233.75Cr 16TCr 237.65Cr 1.59TCr 624.83Cr 7.73TCr 619.39Cr 605.99Cr 27TCr
Net Debt -85Cr -74Cr -68Cr -63Cr -120.29Cr -8.1TCr -122.3Cr -820.31Cr -321.56Cr -3.98TCr -318.76Cr -311.87Cr -14TCr -158.8Cr -138.92Cr -128.11Cr -118.53Cr -224.98Cr -15TCr -228.74Cr -1.53TCr -601.4Cr -7.44TCr -596.16Cr -583.27Cr -26TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
09/26/09 $208.45 +1.27% 14,79,036
08/26/08 $205.84 -6.33% 17,61,755
07/26/07 $219.75 +0.62% 17,26,352
06/26/06 $218.40 +4.18% 37,22,027
02/26/02 $209.63 +4.24% 11,44,252
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
208.45USD
Average target price
257.07USD
Spread / Average Target
+23.32%

Quarterly revenue - Rate of surprise